This is a preprint.
ADPriboDB v2.0: An Updated Database of ADP-ribosylated Proteins
- PMID: 32995784
- PMCID: PMC7523110
- DOI: 10.1101/2020.09.24.298851
ADPriboDB v2.0: An Updated Database of ADP-ribosylated Proteins
Update in
-
ADPriboDB 2.0: an updated database of ADP-ribosylated proteins.Nucleic Acids Res. 2021 Jan 8;49(D1):D261-D265. doi: 10.1093/nar/gkaa941. Nucleic Acids Res. 2021. PMID: 33137182 Free PMC article.
Abstract
ADP-ribosylation is a protein modification responsible for biological processes such as DNA repair, RNA regulation, cell cycle, and biomolecular condensate formation. Dysregulation of ADP-ribosylation is implicated in cancer, neurodegeneration, and viral infection. We developed ADPriboDB (adpribodb.leunglab.org) to facilitate studies in uncovering insights into the mechanisms and biological significance of ADP-ribosylation. ADPriboDB 2.0 serves as a one-stop repository comprising 48,346 entries and 9,097 ADP-ribosylated proteins, of which 6,708 were newly identified since the original database release. In this updated version, we provide information regarding the sites of ADP-ribosylation in 32,946 entries. The wealth of information allows us to interrogate existing databases or newly available data. For example, we found that ADP-ribosylated substrates are significantly associated with the recently identified human protein interaction networks associated with SARS-CoV-2, which encodes a conserved protein domain called macrodomain that binds and removes ADP-ribosylation. In addition, we create a new interactive tool to visualize the local context of ADP-ribosylation, such as structural and functional features as well as other post-translational modifications (e.g., phosphorylation, methylation and ubiquitination). This information provides opportunities to explore the biology of ADP-ribosylation and generate new hypotheses for experimental testing.
Conflict of interest statement
Conflict of Interest
None.
Figures
Similar articles
-
ADPriboDB 2.0: an updated database of ADP-ribosylated proteins.Nucleic Acids Res. 2021 Jan 8;49(D1):D261-D265. doi: 10.1093/nar/gkaa941. Nucleic Acids Res. 2021. PMID: 33137182 Free PMC article.
-
ADPriboDB: The database of ADP-ribosylated proteins.Nucleic Acids Res. 2017 Jan 4;45(D1):D204-D209. doi: 10.1093/nar/gkw706. Epub 2016 Aug 9. Nucleic Acids Res. 2017. PMID: 27507885 Free PMC article.
-
Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.bioRxiv [Preprint]. 2023 Feb 7:2023.02.07.527501. doi: 10.1101/2023.02.07.527501. bioRxiv. 2023. PMID: 36945431 Free PMC article. Preprint.
-
ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.Curr Pharm Des. 2013;19(4):624-33. Curr Pharm Des. 2013. PMID: 23016858 Review.
-
A role of intracellular mono-ADP-ribosylation in cancer biology.FEBS J. 2013 Aug;280(15):3551-62. doi: 10.1111/febs.12290. Epub 2013 May 10. FEBS J. 2013. PMID: 23590234 Review.
References
-
- Hottiger M.O., Hassa P.O., Lüscher B., Schüler H. and Koch-Nolte F. (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci., 35, 208–219. - PubMed
-
- Di Girolamo M., Dani N., Stilla A. and Corda D. (2005) Physiological relevance of the endogenous mono(ADP-ribosyl)ation of cellular proteins. FEBS J., 272, 4565–4575. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous